Senior clinician appointed next chief scientific adviser
Professor Calum Semple will take up the position on August 5 on an initial three-year term, succeeding Julie Fitzpatrick, who has held the role since 2021.
Prof Semple is a consultant in paediatric respiratory medicine at Alder Hey Children's NHS Foundation Trust, and a professor of outbreak medicine and child health at the University of Liverpool.
Raised in Glasgow and Edinburgh, he has held key advisory roles during recent public health emergencies, including serving as a UK Government adviser during the 2009 swine flu pandemic.
He was also part of the World Health Organisation Scientific Advisory Committee during the Ebola emergency, and part of the Scientific Advisory Group for Emergencies (Sage) during the Covid-19 pandemic.
Speaking following his appointment, Prof Semple said: 'I am thrilled to have this opportunity to work for the people and Government of Scotland, providing evidence and scientific advice to support our policymakers.
'I particularly look forward to collaborating with Scotland's vibrant communities of scientists and engineers in our schools, universities and industries, who inspire and drive the innovation essential for future economic growth.
'I will ensure that science and evidence remain at the heart of how we shape a fairer, greener, and more prosperous Scotland.'
The role of CSA includes providing Scottish ministers with independent scientific advice on key issues, and 'championing' the country's science and research base.
He will also play a role in inspiring the next generation of scientists and encourage diversity in the science, technology engineering and mathematics (Stem) workforce.
Business Secretary Richard Lochhead said: 'I am delighted to welcome Professor Semple to the role of CSA and look forward to his valuable insight and advice as the Scottish Government continues to work with our world leading science sector to highlight Scotland's strengths as a science nation and ensure it is front and centre of everything we do.'
Prof Semple added: 'I would like to thank my wife, friends, and colleagues at the University of Liverpool and Alder Hey Children's Hospital who support my career and enabled this important appointment.
'Their encouragement and collaboration have been vital to my journey.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
35 minutes ago
- BBC News
First doctors graduate after completing new part-time course
A group of medical students have become the first cohort of doctors to qualify by studying new graduates formally secured their qualification at the University of Edinburgh after completing the HCP-Med for Healthcare Professionals up in 2018, the five-year scheme encourages professionals in other areas of healthcare to consider studying to become has a strong emphasis on GP placements in the hope of boosting the numbers of general practitioners entering Scotland's NHS. The university said it was "proud" to be the first to produce graduates, numbering 20 in total, from the course. Designed to address the increasing demand on the healthcare workforce, the programme was launched with the aim of offering increased health workers such as nursing staff, clinical scientists and veterinary surgeons could continue to work while undergraduate programme - run by the University of Edinburgh's Medical School - is the first of its kind in the first three years is conducted part-time and predominantly the part-time study, students also receive full funding from the Scottish Funding Council making it an attractive route to retrain those already working in completing their remote studies, students then join the university's full-time undergraduate medical programme for the final two years, undertaking a range of clinical placements in hospital wards and GP issue it addresses is underrepresentation from students from rural areas and less advantaged backgrounds. The university said aiming the programme at experienced professionals opened up a key avenue to people who had not previously considered a career as a doctor. From ICU nurse to doctor Calum MacDonald is a graduate from the first cohort of the HCP-Med programme, having started his career as a staff nurse in an intensive care unit in experience in ICU and subsequent training to become an advanced critical care practitioner – a role he has held since 2016 – led him to consider a career as a programme allowed Dr MacDonald to stay in Glasgow and juggle work and part-time study, while also managing family life after he became a father in his second a newly qualified doctor, he has secured a foundation post in Glasgow and will rotate across seven the two-year foundation programme, Dr MacDonald is considering specialising in anaesthetics or general after the ceremony at the McEwan Hall, he said: "It's been a challenging but incredibly rewarding journey. "Being able to continue working as a nurse while studying medicine was a huge financial incentive. "I am delighted to be graduating today and am excited to start my placement as a junior doctor in Glasgow." Edinburgh medical course offers 'new pathway' Dr Jen Kennedy, the HCP-MED programme director, said: "We have lots of incredibly talented people working within the NHS in Scotland who may have missed the traditional route to become doctors. "By creating this new pathway and widening access to medical degrees, we are able to nurture their talent and use their valuable experience to enhance the healthcare workforce".Prof David Kluth, head of Edinburgh Medical School, said he as proud that Edinburgh was the first university in the UK to offer the programme. He added: "The students on this programme bring with them a rich diversity of backgrounds, experiences and skills - from prior careers to lived experience of the communities they will serve. "This breadth of talent and perspective is vital in building a more inclusive, adaptable, and effective medical workforce for Scotland."
The Independent
5 hours ago
- The Independent
What's behind the global surge of new Covid variant XFG – and should you get vaccinated?
A new Covid variant, XFG, is spreading across the world, with Southeast Asia countries reporting a surge in cases. In the UK, the Health Security Agency has said the variant accounted for 30 per cent of cases in England in late June. However, the true extent of the variant's spread remains uncertain, largely due to a significant reduction in Covid-19 testing compared to the peak of the global pandemic five years ago. What do we know about the variant XFG? XFG is a mix of earlier variants LF.7 and LP.8.1.2, with the earliest sample collected on 27 January 2025, according to the WHO. As of 22 June 2025, there were 1648 XFG sequences detected from 38 countries, representing 22.7 per cent of the global cases that week, up from 7.4 per cent four weeks prior. The variant has been the fastest growing in the last month compared to any other currently circulating types. Recent reports from Southeast Asian countries have shown a simultaneous rise in cases and hospitalisations of this variant. However WHO has designated the risk of this new variant as 'low' and commented that current data do not indicate that this variant leads to more severe illness or deaths than other variants in circulation. Why has there been a surge in new cases? The World Health Organization (WHO) lists Stratus as one of its 'variants under monitoring', which means they may require prioritised attention and tracking by health authorities due to their increased prevalence and potential public health implications. The WHO has said the growth advantage this variant has over others is 'moderate', as XFG is growing substantially across all WHO regions. Data shows from the week of 5 May to the week of 26 May, XFG has increased in proportion across main global regions, including from 10.6 per cent to 16.7 per cent in Europe and from 7.8 per cent to 26.5 per cent in the Americas (AMR). In Southeast Asia, the XFG proportion increased from 17.3 per cent to 68.7 per cent in the Southeast Asia Region (SEAR). 'It is normal for viruses to mutate and change over time,' Dr Alex Allen, consultant epidemiologist of UKHSA said, adding that it continues to monitor all strains of Covid in the UK What are the symptoms? One reported symptom of Stratus is a hoarse throat, according to some experts. 'One of the most noticeable symptoms of the Stratus variant is hoarseness, which includes a scratchy or raspy voice', Dr Kaywaan Khan, Harley Street GP and founder of Hannah London Clinic, told Cosmopolitan UK He said in general, the symptoms of Stratus tend to be 'mild to moderate'. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness. Should you get vaccinated? Under UK guidelines, people aged 75 years and older, residents in care homes for older people, and those aged 6 months and over with a weakened immune system were offered a dose of Covid-19 vaccine this spring. Patients were offered an appointment between April and June, with those at highest risk being called in first. If you are turning 75 years of age between April and June, you do not have to wait until your birthday; you can attend when you are called for vaccination. For the next round of vaccinations, patients will be able to book from 1 September 2025 for vaccines to be given from 1 October, NHS England has advised health providers. The NHS will get in touch to offer you the Covid vaccine if you are eligible.
Medical News Today
9 hours ago
- Medical News Today
Radiotherapy for breast cancer linked to lower Alzheimer's risk
A cohort study led by researchers from Samsung Medical Center in South Korea examined the prevalence of Alzheimer's disease in breast cancer survivors. The scientists compared the prevalence of Alzheimer's to the different methods of cancer treatment and also to a group of healthy women. The researchers found that breast cancer survivors treated with radiation therapy had an 8% reduced risk of developing Alzheimer's in the short term. Breast cancer is one of the most common cancers among women, and according to the American Cancer Society, women have a one in eight chance of developing it at some point. At the same time, Alzheimer's disease is another public health challenge. According to the Alzheimer's Association, it affects an estimated seven million people in the United States researchers noted that a common concern with cancer treatments is that they may cause long-term cognitive side effects, so they explored whether breast cancer treatments impact the chances of developing Alzheimer's. The researchers published their findings in JAMA Network for breast cancer: Is there a link with Alzheimer's risk? Breast cancer has a 5-year relative survival rate of 91%. Treatment depends on whether the cancer is localized or has metastasized (spread beyond the breast). Localized breast cancer is easier to treat, while metastatic breast cancer is more challenging and requires more aggressive ways doctors treat breast cancer include: surgery such as a lumpectomy or mastectomy radiation therapy (also known as radiotherapy)hormone (endocrine) therapytargeted early-stage breast cancer often involves radiation therapy as part of the treatment. Around 70% of women with breast cancer have radiation therapy, and approximately 40% receive chemotherapy. These cancer treatments can cause some serious side effects; radiation therapy can cause hair loss, fatigue, and cognitive impairment. Some side effects of chemotherapy include fatigue, neuropathy, and cognitive changes (chemo brain). The scientists involved in the new study utilized data from the Korean National Health Insurance Service to examine Alzheimer's risk in breast cancer survivors. They included a group of around 70,000 breast cancer survivors and a control group of around 180,000 women. The participants underwent cancer surgery and treatment between 2010 and 2016; the researchers used an average of 7 years of follow-up data for the breast cancer survivors. The most common cancer treatment for the group was radiation, which 71.7% of the group received. More than half of the women received chemotherapy drugs, and nearly half received hormone treatments. Radiotherapy linked to lower short-term Alzheimer's riskDuring the follow-up period, 1,229 women in the breast cancer group received an Alzheimer's diagnosis. When compared to the control group, women who had undergone breast cancer treatment showed an 8% lower risk of developing Alzheimer's. This risk reduction was most pronounced among women who underwent radiation therapy, which made the researchers believe that radiation may have been responsible for the lowered risk of Alzheimer' the scientists observed that this protective effect went away with time. 'Based on these findings, we hypothesize that the risk of [Alzheimer's dementia] could be lowered shortly after cancer treatment but may equalize as the survival period increases,' the authors radiation therapy showed a potential protective benefit, the study found no significant impact on Alzheimer's risk from other authors emphasize the need for further research, noting that the maximum follow-up period in this study was just 11 years, which was potentially too short to fully understand the long-term relationship between breast cancer treatments and Alzheimer's might radiotherapy protect cognitive health?Jon Stewart Hao Dy, MD, a board-certified neurologist affiliated with the Philippines Neurological Association, told Medical News Today that he did not find the study findings surprising. Dy, who was not involved in the current study, told us that:'When a patient is diagnosed with breast cancer and undergoes the necessary evidence-based treatment, including surgery, chemotherapy, and radiotherapy, they are likely to receive adequate and prompt treatment to control their other comorbidities and to prevent the long-term risk of chemotherapy-induced cognitive dysfunction.'He also touched on why radiation therapy may have provided short-term benefit against developing Alzheimer's. 'The biological mechanisms behind this lower short-term risk are the potential of radiotherapy to reduce astrogliosis and microgliosis and have anti-inflammatory and neuroprotective effects,' explained said that people who are looking to reduce their long-term risk of developing Alzheimer's should focus on controlling vascular risk factors such as blood pressure and Bashir, MD, a board-certified neurologist at AICA Orthopedics, likewise not involved in the study, told MNT that the findings indicating that radiation potentially provided short-term benefit were 'fascinating.''While the results are preliminary and warrant cautious interpretation, they open the door to meaningful hypotheses about underlying mechanisms,' said suggested that radiation therapy might influence the immune system or interfere with the formation of amyloid plaques, both of which are associated with Alzheimer's pathology.'Additionally, estrogen plays a complex role in both cancer biology and neurodegeneration,' shared Bashir. 'Lowering estrogen levels through hormone therapy may, paradoxically, reduce Alzheimer's risk in some patients.'Bashir emphasized that more long-term research is needed in this area. 'This study is encouraging in that it challenges assumptions and suggests that certain cancer-related treatments may influence dementia risk in unexpected ways,' said Bashir. 'More longitudinal research will be critical in clarifying these associations.'
